Kaitlyn Arsenault - 28 Oct 2024 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SKYE	Stock Option (Right to Buy)	Award	$0	+125,000		$0.000000	125,000	28 Oct 2024	Common Stock	125,000	$5.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests in equal monthly installments over the four year period beginning October 28, 2024.